Efficacy and Safety of Biosimilar CT-P47 Versus Reference Tocilizumab: 1-Year Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study in Patients with Rheumatoid Arthritis. - Burmester G; Trefler J; Racewicz A; Jaworski J; Zielińska A; Krogulec M; Jeka S; Wojciechowski R; Kolossa K; Dudek A; Krajewska-Włodarczyk M; Hrycaj P; et al. (Clinical drug investigation, 2025)